FIRST AMENDMENT TO AMENDED AND RESTATEDIvd Test Development and Component Supply Agreement • May 9th, 2019 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments
This First Amendment to Amended and Restated IVD Test Development and Component Supply Agreement (the “Agreement”) is effective as of April 3, 2019 (the “Amendment Effective Date”) and is made by and between Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, California 92122, (“Illumina”) and HTG Molecular Diagnostics, Inc., a Delaware corporation having a place of business at 3430 E Global Loop, Tucson, Arizona 85706 (“Company”). Illumina and Company may also individually be referred to herein as a “Party” and collectively as the “Parties.”
